Our findings of the impact of HFD-induced obesity on the anti-tumor activity of CD4+ T cells may provide a clue to elucidate the pathogenesis of poor outcomes of CRC with obesity comorbidities. This evidence concerns the gene CD4 and obesity due to melanocortin 4 receptor deficiency.